PathAI Review 2026

Name: PathAI
Brand: PathAI
Rating: 4.5 (11 reviews)

Honest pros, cons, and verdict on this automation & workflows tool

✅ AISight Dx has FDA clearance for primary diagnosis in the United States and is CE-IVD marked for primary diagnosis in the EEA, UK, and Switzerland.

Starting Price

Custom quote

Free Tier

What is PathAI?

AI-powered digital pathology platform providing FDA-cleared digital pathology image management, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.

PathAI is an enterprise AI and digital pathology platform for laboratories, health systems, academic medical centers, reference labs, and biopharma teams that need whole-slide image management, workflow tooling, and pathology AI access; pricing is not publicly listed and appears to be handled through custom enterprise contracts. Its core platform is AISight, a cloud-native digital pathology image management and enterprise workflow system used as a central hub for case management, image management, whole-slide review, and access to PathAI and third-party AI applications. The company positions AISight for both clinical digital pathology workflows and research or clinical trial workflows, with AISight Dx specifically cleared by the FDA for primary diagnosis in the United States and CE-IVD marked for primary diagnosis in the EEA, UK, and Switzerland. PathAI states that AISight Dx is FDA-cleared for use with Hamamatsu NanoZoomer S360MD and Leica Aperio GT 450 DX scanners.

For biopharma, PathAI focuses on pathology workflows across drug development, biomarker discovery, histology assessment, and clinical trial endpoint standardization. The company offers AI products such as AIM-PD-L1 for PD-L1 quantification, AIM-HER2, AIM-ER, AIM-PR, AIM-Ki-67, AIM-MASH+, MET Dysregulation NSCLC, AIM-HI, PathAssist Derm, PathExplore, and workflow tools such as ArtifactDetect, TumorDetect, and AIM-TumorCellularity. Many of these algorithms are described by PathAI as Research Use Only in the United States and not for diagnostic procedures, so buyers should distinguish carefully between the FDA-cleared AISight Dx image management system and individual AI algorithms intended for research, workflow support, or clinical trial use.

Key Features

✓Whole-slide image management

✓Digital pathology case workflows

✓Biomarker quantification

✓Clinical trial pathology support

✓Scanner workflow integration

✓Regulatory and compliance support

Pricing Breakdown

Enterprise Platform

Custom quote; no public list price

per month

Biopharma Services

Custom quote; no public list price

per month

AI Product Access

Custom quote; no public list price

per month

Pros & Cons

✅Pros

•AISight Dx has FDA clearance for primary diagnosis in the United States and is CE-IVD marked for primary diagnosis in the EEA, UK, and Switzerland.
•Designed for enterprise digital pathology workflows, including case management, image management, workflow tools, and access to AI applications from a central cloud-native platform.
•Strong biopharma orientation, with products and services for biomarker discovery, histology assessment, drug development, and clinical trial endpoint standardization.
•Large pathology data and expertise base, including a stated network of 450+ board-certified pathologists and 32.5M+ contributed annotations used to support algorithm development and validation.
•Broad AI product menu covering areas such as PD-L1, HER2, ER, PR, Ki-67, MASH, inflammatory bowel disease, tumor cellularity, artifact detection, and tumor microenvironment analysis.
•Recent large-scale partnerships, including Labcorp's expanded deployment of AISight Dx and MedStar Health's partnership to deploy AISight Dx and advanced AI applications.

❌Cons

•Pricing is not public, so laboratories and sponsors must engage sales to understand total cost, implementation scope, and contract structure.
•Several PathAI algorithms are explicitly described as Research Use Only in the United States and not for diagnostic procedures, which limits direct clinical diagnostic use cases.
•Deployment depends on digital pathology infrastructure such as slide scanners, image workflows, validation processes, and lab change management.
•AISight Dx scanner support is specific; PathAI lists FDA-cleared use with Hamamatsu NanoZoomer S360MD and Leica Aperio GT 450 DX scanners.
•The platform is specialized for pathology organizations and biopharma teams, making it a poor fit for general healthcare AI automation, patient engagement, or routine clinical note-taking.

Who Should Use PathAI?

✓Deploying an FDA-cleared digital pathology image management system for primary diagnosis in eligible U.S. clinical settings.
✓Standardizing histopathology review and endpoint assessment in biopharma clinical trials.
✓Running AI-assisted biomarker quantification workflows such as PD-L1, HER2, ER, PR, and Ki-67 analysis.
✓Using H&E whole-slide images to analyze tumor microenvironment features through PathExplore.
✓Supporting MASH clinical trial enrollment and endpoint assessment with AIM-MASH AI Assist where regulatory qualification applies.
✓Modernizing laboratory digital pathology operations across multiple sites with image management, workflow tooling, and AI application access.

Who Should Skip PathAI?

×You're on a tight budget
×You're concerned about several pathai algorithms are explicitly described as research use only in the united states and not for diagnostic procedures, which limits direct clinical diagnostic use cases.
×You're concerned about deployment depends on digital pathology infrastructure such as slide scanners, image workflows, validation processes, and lab change management.

Alternatives to Consider

Glass AI

Clinical decision support AI that assists healthcare professionals with differential diagnosis, medical knowledge search, and evidence-based clinical reasoning.

Starting at Freemium

Learn more →

Viz.ai

AI-powered medical imaging platform that accelerates diagnosis and treatment of critical conditions

Starting at Paid

Learn more →

Regard

AI clinical insights platform that reviews 100% of patient charts to support hospital documentation, diagnosis capture, and revenue integrity workflows.

Starting at Custom enterprise pricing; exact starting price not public

Learn more →

Our Verdict

✅

PathAI is a solid choice

PathAI delivers on its promises as a automation & workflows tool. While it has some limitations, the benefits outweigh the drawbacks for most users in its target market.

Try PathAI →Compare Alternatives →

Frequently Asked Questions

What is PathAI?

AI-powered digital pathology platform providing FDA-cleared digital pathology image management, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.

Is PathAI good?

Yes, PathAI is good for automation & workflows work. Users particularly appreciate aisight dx has fda clearance for primary diagnosis in the united states and is ce-ivd marked for primary diagnosis in the eea, uk, and switzerland.. However, keep in mind pricing is not public, so laboratories and sponsors must engage sales to understand total cost, implementation scope, and contract structure..

How much does PathAI cost?

PathAI starts at Custom quote. Check their pricing page for the most current rates and features included in each plan.

Who should use PathAI?

PathAI is best for Deploying an FDA-cleared digital pathology image management system for primary diagnosis in eligible U.S. clinical settings. and Standardizing histopathology review and endpoint assessment in biopharma clinical trials.. It's particularly useful for automation & workflows professionals who need whole-slide image management.

What are the best PathAI alternatives?

Popular PathAI alternatives include Glass AI, Viz.ai, Regard. Each has different strengths, so compare features and pricing to find the best fit.

More about PathAI

Pricing Alternatives Free vs Paid Pros & Cons Worth It?Tutorial

📖 PathAI Overview 💰 PathAI Pricing 🆚 Free vs Paid 🤔 Is it Worth It?

Last verified March 2026

What is PathAI?

AI-powered digital pathology platform providing FDA-cleared digital pathology image management, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.

Pros & Cons

✅Pros

•AISight Dx has FDA clearance for primary diagnosis in the United States and is CE-IVD marked for primary diagnosis in the EEA, UK, and Switzerland.
•Designed for enterprise digital pathology workflows, including case management, image management, workflow tools, and access to AI applications from a central cloud-native platform.
•Strong biopharma orientation, with products and services for biomarker discovery, histology assessment, drug development, and clinical trial endpoint standardization.
•Large pathology data and expertise base, including a stated network of 450+ board-certified pathologists and 32.5M+ contributed annotations used to support algorithm development and validation.
•Broad AI product menu covering areas such as PD-L1, HER2, ER, PR, Ki-67, MASH, inflammatory bowel disease, tumor cellularity, artifact detection, and tumor microenvironment analysis.
•Recent large-scale partnerships, including Labcorp's expanded deployment of AISight Dx and MedStar Health's partnership to deploy AISight Dx and advanced AI applications.

❌Cons

•Pricing is not public, so laboratories and sponsors must engage sales to understand total cost, implementation scope, and contract structure.
•Several PathAI algorithms are explicitly described as Research Use Only in the United States and not for diagnostic procedures, which limits direct clinical diagnostic use cases.
•Deployment depends on digital pathology infrastructure such as slide scanners, image workflows, validation processes, and lab change management.
•AISight Dx scanner support is specific; PathAI lists FDA-cleared use with Hamamatsu NanoZoomer S360MD and Leica Aperio GT 450 DX scanners.
•The platform is specialized for pathology organizations and biopharma teams, making it a poor fit for general healthcare AI automation, patient engagement, or routine clinical note-taking.

Who Should Use PathAI?

✓Deploying an FDA-cleared digital pathology image management system for primary diagnosis in eligible U.S. clinical settings.
✓Standardizing histopathology review and endpoint assessment in biopharma clinical trials.
✓Running AI-assisted biomarker quantification workflows such as PD-L1, HER2, ER, PR, and Ki-67 analysis.
✓Using H&E whole-slide images to analyze tumor microenvironment features through PathExplore.
✓Supporting MASH clinical trial enrollment and endpoint assessment with AIM-MASH AI Assist where regulatory qualification applies.
✓Modernizing laboratory digital pathology operations across multiple sites with image management, workflow tooling, and AI application access.

Who Should Skip PathAI?

×You're on a tight budget
×You're concerned about several pathai algorithms are explicitly described as research use only in the united states and not for diagnostic procedures, which limits direct clinical diagnostic use cases.
×You're concerned about deployment depends on digital pathology infrastructure such as slide scanners, image workflows, validation processes, and lab change management.

Alternatives to Consider

Glass AI

Clinical decision support AI that assists healthcare professionals with differential diagnosis, medical knowledge search, and evidence-based clinical reasoning.

Starting at Freemium

Learn more →

Viz.ai

AI-powered medical imaging platform that accelerates diagnosis and treatment of critical conditions

Starting at Paid

Learn more →

Regard

AI clinical insights platform that reviews 100% of patient charts to support hospital documentation, diagnosis capture, and revenue integrity workflows.

Starting at Custom enterprise pricing; exact starting price not public

Learn more →

Frequently Asked Questions

What is PathAI?

AI-powered digital pathology platform providing FDA-cleared digital pathology image management, biomarker analysis, and enterprise workflow management for laboratories and biopharma companies.

Is PathAI good?

How much does PathAI cost?

PathAI starts at Custom quote. Check their pricing page for the most current rates and features included in each plan.

Who should use PathAI?

What are the best PathAI alternatives?

Popular PathAI alternatives include Glass AI, Viz.ai, Regard. Each has different strengths, so compare features and pricing to find the best fit.